companydata.dkcompanydata.dk

PHARMAVEST ApS: Financial statements 2020

CVR: 26385180

Source: annual report 2020, Danish Business Authority

01/01/202031/12/2020

PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,159,046 and a net result of DKK 281,262 compared with DKK 817,782 the year before. That is a decrease of 34.6% compared with the year before. Equity in the 2020 report amounted to DKK 3,803,783. The solvency ratio was 73.3%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,159,046
Profit/Loss
DKK 281,262
Equity
DKK 3,803,783
Total Assets
DKK 5,191,543
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.2 mio.281 t.3.8 mio.1
2019-1.8 mio.818 t.3.6 mio.1
2018-1.1 mio.360 t.2.9 mio.1
2017-338 t.-261 t.2.6 mio.1
2016-479 t.-94 t.2.8 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAVEST ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

PHARMAVEST ApS: The 2019 annual report is outAug 28, 2020

PHARMAVEST ApS has published its annual report for 2019. Gross profit came to DKK 1,771,479, and the net result was DKK 817,782.

About PHARMAVEST ApS

PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.

Source: annual report 2025, Danish Business Authority